Dyne Therapeutics
Cole Szeman is a Computational Biology major at Colby College, expected to graduate in 2026. Currently serving as a Data Science Research Intern at Dyne Therapeutics and a Lunder Bioinformatics Fellow at The Jackson Laboratory, Cole is focused on designing software pipelines for genome sequence variant analysis. Previous experience includes conducting cancer immunotherapy research at Mass General Hospital, interning in ecosystem restoration and water sanitization at EcoSwell, and tutoring chemistry at Colby College. Additional roles have included serving as a head camp counselor and shadowing in an orthopedic department at BronxCare Health System. Cole also participated in a study abroad program through DIS from January to May 2025.
This person is not in any teams
This person is not in any offices
Dyne Therapeutics
4 followers
Dyne is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases.